Clinical Trial Update: Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of dapagliflozin on blood pressure variability in individuals with prediabetes and prehypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Prehypertension

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Guadalajara | Conditions: PreDiabetes, Prehypertension | Phase 4 | Status: COMPLETED | Results posted: 2020-10-19